|
|
| Industrie Pharmaceutique > Etude de marché sectorielle |
| Ephedrine Production & Market in China |
|
|
|
|
€ 5 200,00 |
Editeur
: |
CCM International, ltd. |
Langue
: |
Anglais |
Date de publication : |
Mars 2006 |
Taille du document : |
152 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Patient Power in the Pharmaceutical Industry: The shift towards more informed, more powerful consumers of drugs 119 pages | Juin 1999 |
The dramatic rise in patient power in recent years presents a new and challenging opportunity to pharmaceutical companies, healthcare providers and governments alike. A great need exists for ph |
795,00 €
|
| |
| |
Regulatory Affairs: Paths to Approval 113 pages | Février 1999 |
Area Specific Chapters : The regulatory systems governing clinical trials and drug approvals are examined for the US, Europe, and Australia, Canada and Japan, including analysis of the implicatio |
795,00 €
|
| |
| |
The Drug Delivery Outlook 2001 176 pages | Juillet 2001 |
In an environment where there is constant pressure to launch new products onto the market, the cost of investment in drug delivery compares very favourably with new drug discovery. Subseque |
955,00 €
|
| |
| |
Chinese Markets for OTC Drugs 220 pages | Février 2002 |
China's demand for OTC drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trend |
3 500,00 €
|
| |
| |
Pharmaceutical Pricing Strategies 121 pages | Juillet 1998 |
Which pricing strategies will enable your company to maximise profitability? As healthcare cost-containment intensifies and pricing freedom is eroded, the need to develop new strategies to mainta |
795,00 €
|
| |
| |
The Pharmaceutical Industry Paradox: A strategic analysis of the countertrends of consolidation and fragmentation 128 pages | Mai 2002 |
The pharmaceutical industry currently represents a huge paradox. Whilst the pursuit of critical mass has driven consolidation and brought about the creation of mega-companies such as Pharmacia, Gla |
953,48 €
|
| |
| |
Bridging the Pharmaceutical Earnings gap: Key Strategies in the race for growth 173 pages | Mars 2000 |
The favorable climate of the pharmaceutical sector has changed radically over the past ten years. Where once near unrestricted revenue expansion existed, external pressures now act in unison |
955,00 €
|
| |
| |
The Pharmaceutical Outsourcing Outlook 1998-2003 199 pages | Juin 1999 |
The streamlining of pharmaceutical companies that has taken place in recent years has allowed them to focus resources and investment on core specialities. This, in turn, has led to a greater re |
795,00 €
|
| |
| |
Chinese Markets for Pharmaceuticals 225 pages | Janvier 2002 |
China's demand for pharmaceuticals has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic |
2 835,00 €
|
| |
| |
The Drug Discovery Outlook: Drivers of innovation in the 21st Century 189 pages | Octobre 2000 |
The Drug Discovery Outlook: Drivers of innovation in the 21st Century introduces and analyzes the five key enabling technologies and bioinformatics, which are currently driving pharmaceutical dru |
955,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Ephedrine Production & Market in China |
|
|
There have been new changes to China’s ephedrine industry in recent three years (2004~2006), in output, production method and government's role, etc. In the coming several years, how will the ephedrine industry in China go? You can find the answers after reading this report. The report thoroughly discusses the supply situation of ephedra and the government's role. Moreover, the report examines production, import & export, consumption, production technology. Future forecast on ephedrine industry in next 5 to 10 years has been conducted.
Xinjiang Heshuo Ephedrine Products Co., Ltd.; Zhejiang Kangyu Pharmaceutical Co., Ltd.; China Medicines (Group) Corporation; China National Medicines & Health Product Import & Export Corporation; Beijing Pharmaceutical Co., Ltd.
|
|
TABLE OF CONTENT
Executive Summary Introduction and Definitions I Production and Market I-1 Ephedra Resources in China I-1.1 Ephedrine Content in Ephedra & Properties of Chinese Ephedra I-1.2 Ephedra Species & Distribution in China I-1.3 Growth & Plantation of Ephedra in China I-1.4 Collection of Ephedra in China (Natural & man-growth) I-2 Brief History of Ephedrine Production in China I-3 Current Situation of Ephedrine Production in China (L-ephedrine, pseudo ephedrine, methyl ephedrine and ephedra extract powder) I-4 Brief Introduction to the Synthetic Ephedrine in China I-5 Import & Export Analysis 1.5.1 I/E Analyze of L-Ephedrine and Pseudo-Ephedrine in June 1999 1.5.2 I/E Analyze of Ephedrine Serials in Recent Years 1.5.3 Sales Channels for Export I-6 Pricing of Ephedrine in the Past I-7 Consumption Pattern Ephedrine & Pseudo-ephedrine in China I-8 Government Control I-8.1 List of Relative Regulation I-8.2 Management on Ephedrine Production I-8.3 Management on Ephedrine Distribution I-8.4 Management on Ephedrine Import & Export I-9 Key Factors and Driven Forces for the Development of Ephedrine in China II Technology II-1 Extraction Process of Ephedrine II-2 Chinese Approach to Synthetic Ephedrine & Current Progress III Future Forecast on Ephedrine in the Next 5-10 Years IV Appendix IV-1 Active Producers Profile IV-1-01 Xinjiang Heshuo Ephedrine Products Co., Ltd. ……. IV-1-04 Guangdong Shenzhen Orient Pharmaceutical Co., Ltd. IV-2 Idle Producers Profile IV-2-01 Xinjiang Gongliu Ephedrine Manufactory ………… IV-2-17 Xinjiang Wenquan ephedrine Manufactory IV-3 Stopped producers Profile IV-3-01 Taonan Pharmaceutical Manufactory of Jilin Traditional Chinese Medicine Academy …… IV-3-11 Jiangsu Zhongbang Pharmacy Co., Ltd. IV-4 List of Companies Licensed to Export Ephedrine & Its Derivatives IV-5 List of Narcotic Drugs Distributors in China IV-6 Notice as to Publish the Reappraisal Result of Drug Local Standard about Respiratory-System Medicine, Vitamin & Mineral Medicine (SDA NO.131 [2000])
LIST OF TABLES Table I-1.2.1 Ephedrine content in some major ephedra species (Unit: %) Table I-1.3.1 The plantation and production situation of ephedra has been listed in the following table. Table I-1.3.2 Ephedra distribution in Xinjiang Table I-1.3.3 The estimated resource of ephedra below Table I-1.4 Collection plan for ephedra in 2002 (unit: MT) Table I-2.1 Ephedrine serials manufacturers stopping production since 1997 Table I-1.2-2 Output of Ephedrine in China, 1991-2005, unit: MTs Table I-3.1 Output of ephedrine serials in 2005 Table I-3.2 Active and idle manufacturers of ephedrine serials in 2006 (Unit: MTs) Table I-3.3 Active and idle manufacturers of L-ephedrine and Pseudo-ephedrine in 2006 Table Manufacturers of Ephedra PE in 2006 Table I-5.1.1 Export of L-Ephedrine and Pseudo-Ephedrine Table I-5.1.2 Export of L-Ephedrine and Pseudo-Ephedrine Table I-5.1.3. Comparison of the export quantity of L-ephedrine and pseudo-ephedrine in 1996, 1997 & 1998 Table I-5.1.4 Comparison of the quantity of ephedrine produced from different production origin Table I-5.1.5 Comparison of the export quantity of ephedrine to different countries in 1998. Table I-5.2.1 Export price of Ephedrine serials in 2003 Table I-5.2.2 Export destination of Ephedrine serials in 2003 Table I-5.2.3 Active exporter of Ephedrine serials in 2003 Table I-5.2.4 Export situation of Ephedrine serials manufacturers in 2003 Table I-5.2.5 Export price of Ephedrine serials in 2004 Table I-5.2.6 Export destination of Ephedrine serials in 2004 Table I-5.2.7 Active exporter of Ephedrine serials in 2004 Table I-5.2.8 Export situation of Ephedrine serials manufacturers in 2004 Table I-5.2.9 Export price of Ephedrine serials in 2005 Table I-5.2.10 Export destination of Ephedrine serials in 2005 Table I-5.2.11 Active exporter of Ephedrine serials in 2005 Table I-5.2.12 Export situation of Ephedrine serials manufacturers in 2005 Table I-5.3.1 Active exporters in 2005 Table I-5.3.2 Transportation method in 2005 Table I-5.3.3 Port for ephedrine serials export in 2005 Table I-6.1.1 Price of ephedrine in March 2006 Table I-6.2.1 Average export price of Ephedrine serials Table I-6.2.2 Sale price of Ephedrine serials in March 2006 (FOB Tianjin, USD/kg) Table I-7.1 Demand of ephedrine serials in the world Table I-7.2 Major consumers of ephedrine serials Table I-8.4.1 List of ephedrine products that need export licenses (from Jan 2003) Table I-9.1 Percentage of ephedrine serials export by country in 2005
|
|
|
PPLSEN
|
|
|
|
|